Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S. epidermidis that is in a Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor targeted therapy; ATR-12, a genetically modified strain of S. epidermidis, which is in a Phase 1b/2a clinical trial for treating Netherton syndrome, a skin disease; and ATR-01, a genetically modified strain of S. epidermidis that expresses an engineered recombinant human filaggrin protein, which is in the IND-enabling phase for treating ichthyosis vulgaris, a skin disease. It has a joint development agreement with Bayer for the identification and characterization of S. epidermidis strains for topical formulations. Azitra, Inc. was incorporated in 2014 and is headquartered in Branford, Connecticut.
Frequently asked questions
What sector does Azitra Inc (AZTR) operate in?
Azitra Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Azitra Inc (AZTR) current stock price?
As of the latest data, Azitra Inc stock price is $1.66, with a previous close of $0.72. Azitra Inc gained $0.95 in the last trading session, representing a 132.17% increase.
What is Azitra Inc (AZTR) current market capitalization?
Azitra Inc market cap is approximately 100.60 million.
What is Azitra Inc (AZTR) Earnings Per Share (EPS)?
The trailing EPS is -$0.28, and the forward EPS is -$0.10.
What is Azitra Inc (AZTR) EBITDA?
Azitra Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 3.46 million.
Does Azitra Inc (AZTR) pay dividends?
No. Azitra Inc does not pay a dividend.
When is Azitra Inc (AZTR) next earnings report?
Azitra Inc is expected to release its next earnings report on September 30, 2026.
What is Azitra Inc (AZTR) beta (volatility) score?
Azitra Inc has a beta of -1.040, indicating lower volatility than the overall market.
